Diabetes
Conference Coverage
SUSTAIN FORTE: Higher-dose semaglutide safely boosts glycemic control, weight loss
For patients with type 2 diabetes, doubling the weekly semaglutide dose modestly improved glycemic control and weight loss while maintaining...
Conference Coverage
‘Staggering’ doubling of type 2 diabetes in children during pandemic
Two new studies show a shocking increase in type 2 diabetes among U.S. children during the pandemic, with increased severity at presentation....
Conference Coverage
‘Stunning’ twincretin beats semaglutide for A1c, weight reduction in T2D
Head-to-head pivotal trial results show weekly tirzepatide injections surpassed 1 mg semaglutide weekly for A1c reduction and weight loss.
Conference Coverage
Unmanaged diabetes, high blood glucose tied to COVID-19 severity
Findings suggest in part that hospitalized COVID-19 patients need aggressive treatment of hyperglycemia, regardless of the diagnosis of diabetes...
Conference Coverage
Time-restricted eating ‘promising, but more data are needed’
“Time-restricted eating is promising because of its simple message and noted weight-loss benefit, yet more data are needed,” says an expert.
Conference Coverage
Bariatric surgery leads to better cardiovascular function in pregnancy
The cardiovascular benefits of bariatric surgery include reduced hypertension, remodeling of the heart with a reduction in left ventricular mass,...
From the Journals
Stopping statins linked to death, CV events in elderly
A new study suggests that eliminating statins for elderly patients with polypharmacy may have negative effects that far outweigh any benefits.
Conference Coverage
ADA scientific sessions address the old and the new
A new drug class and a rare comparative effectiveness study for type 2 diabetes, management of type 1 diabetes in adults, COVID-19 and diabetes,...
From the Journals
No overall statin effect seen on dementia, cognition in ASPREE analysis
Still, there was an inconclusive link between statins and incident Alzheimer’s dementia in one subgroup of patients in the trial; researchers...
From the Journals
Sotagliflozin use in T2D patients linked with posthospitalization benefits in analysis
The paper’s outcome measure may be a meaningful, patient-centered way of capturing disease burden, according to the authors.
Feature
Medicare rule changes allow for broader CGM use
The Centers for Medicare & Medicaid Services has removed requirements for thrice-daily blood glucose measurement and allowed CGM coverage for...